Literature DB >> 23511643

Influence of the posterior lumbar interbody fusion on the sagittal spino-pelvic parameters in isthmic L5-S1 spondylolisthesis.

Yu Feng1, Liang Chen, Yong Gu, Zhi-Ming Zhang, Hui-Lin Yang, Tian-Si Tang.   

Abstract

STUDY
DESIGN: Prospective study of the sagittal spino-pelvic parameters and deformity parameters in low-grade isthmic spondylolisthesis preoperation and postoperation.
OBJECTIVE: To better understand how the surgery influences sagittal spino-pelvic alignment in low-grade spondylolisthesis. SUMMARY OF BACKGROUND DATA: Over the past decade, the importance of the sagittal spino-pelvic parameters was recognized. However, the postoperative change of sagittal balance parameters in low-grade spondylolisthesis was still unclear.
METHODS: Forty-nine patients (mean age, 53.2±7.2 y) with low-grade L5-S1 isthmic spondylolisthesis and 60 normal volunteers (mean age, 44.5±8.4 y) were included in the study. Each subject had a radiograph that allowed measurement of sagittal spino-pelvic parameters before and after surgery. The follow-up duration was at least 2 years. Sagittal spino-pelvic parameters and deformity parameters were measured for comparison.
RESULTS: Pelvic incidence, pelvic tilt (PT), sacral slope, lumbar lordosis (LL), lumbar 5 incidence, and lumbosacral angle of normal volunteers were smaller than those of spondylolisthesis patients. All of the parameters changed significantly after the posterior lumbar interbody fusion. Postoperative PT reduced by 4.9 degrees, which had no significant difference compared with the control group (P=0.601). The changes of slip degree and height of the intervertebral disk revealed correlation with the increase of LL (r=-0.483, P=0.003; r=0.365, P=0.010).
CONCLUSION: The improvement of PT may play an important role in the reconstruction of the sagittal alignment and therapeutic outcome. The restoration of the slip degree and height of the intervertebral disk would increase the LL with a wedged cage. To get a better LL, the size and geometry of the cage was recommended to be evaluated before surgical treatment.

Entities:  

Mesh:

Year:  2014        PMID: 23511643     DOI: 10.1097/BSD.0b013e31828af6f0

Source DB:  PubMed          Journal:  J Spinal Disord Tech        ISSN: 1536-0652


  6 in total

1.  Correlation between correction of pelvic balance and clinical outcomes in mid- and low-grade adult isthmic spondylolisthesis.

Authors:  Andrzej Maciejczak; Katarzyna Jabłońska-Sudoł
Journal:  Eur Spine J       Date:  2016-10-11       Impact factor: 3.134

2.  Restoration of lumbopelvic sagittal alignment and its maintenance following transforaminal lumbar interbody fusion (TLIF): comparison between straight type versus curvilinear type cage.

Authors:  Jong-Tae Kim; Myung-Hoon Shin; Ho-Jin Lee; Du-Yong Choi
Journal:  Eur Spine J       Date:  2015-03-25       Impact factor: 3.134

3.  Transforaminal lumbar interbody fusion with a silicon nitride cage demonstrates early radiographic fusion.

Authors:  Mitchell T Gray; Kyle P Davis; Bryan J McEntire; B Sonny Bal; Micah W Smith
Journal:  J Spine Surg       Date:  2022-03

Review 4.  Biomaterials for Interbody Fusion in Bone Tissue Engineering.

Authors:  Han Zhang; Zhonghan Wang; Yang Wang; Zuhao Li; Bo Chao; Shixian Liu; Wangwang Luo; Jianhang Jiao; Minfei Wu
Journal:  Front Bioeng Biotechnol       Date:  2022-05-17

5.  The Association Between Sagittal Spinopelvic Alignment and Persistent Low Back Pain After Posterior Lumbar Interbody Fusion for Treatment of Mild L5-S1 Spondylolisthesis: A Retrospective Study.

Authors:  Jian-Jun Yuan; Guang Li; Yan Liu; Quan Zhang; Zhi-Shuai Ren; Rong Tian
Journal:  Int J Gen Med       Date:  2022-05-10

6.  Cervical balance and clinical outcomes in cervical spondylotic myelopathy treated by three-level anterior cervical discectomy and fusion and hybrid cervical surgery: A CONSORT-compliant study with minimum follow-up period of 5 years.

Authors:  Fanqi Meng; Shuai Xu; Yan Liang; Zhenqi Zhu; Kaifeng Wang; Haiying Liu
Journal:  Medicine (Baltimore)       Date:  2021-05-07       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.